Literature DB >> 18801543

Outcomes following partial nephrectomy by tumor size.

Paul L Crispen1, Stephen A Boorjian, Christine M Lohse, Thomas S Sebo, John C Cheville, Michael L Blute, Bradley C Leibovich.   

Abstract

PURPOSE: Pathological evaluation of renal tumors treated with ablative and observational therapy is often limited and renal tumor size may be the only prognostic index available. We established long-term survival in patients following partial nephrectomy according to tumor size.
MATERIALS AND METHODS: A retrospective review of our nephrectomy registry was performed to identify patients who underwent partial nephrectomy for localized (NX/N0/cM0) solid renal tumors 7 cm or less at our institution between 1970 and 2004. Overall, cancer specific, distant metastasis-free and local recurrence-free survival was estimated using the Kaplan-Meier method and stratified according to tumor size in all tumors treated and in patients with pathologically confirmed renal cell carcinoma.
RESULTS: We identified 798 patients who underwent partial nephrectomy for a 7 cm or less renal tumor. Median patient age was 63.5 years and median tumor size was 3.0 cm. Renal cell carcinoma was present in 637 tumors (80%). Overall, cancer specific, metastasis-free and local recurrence-free survival significantly decreased with each 1 cm increase in size in all tumors treated and in those with pathologically confirmed renal cell carcinoma (each p <0.05).
CONCLUSIONS: Partial nephrectomy is associated with durable cancer control in patients with renal tumors 7 cm or less, of which most represent renal cell carcinoma. Tumor size represents a valuable prognostic index in the absence of pathological evaluation of the entire tumor specimen. These results may be used for comparison against outcomes following ablative and observational therapy, for which tumor size is the only prognostic index available.

Entities:  

Mesh:

Year:  2008        PMID: 18801543     DOI: 10.1016/j.juro.2008.07.047

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  34 in total

Review 1.  Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.

Authors:  Cedric Lebacle; Aydin Pooli; Thomas Bessede; Jacques Irani; Allan J Pantuck; Alexandra Drakaki
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

2.  Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.

Authors:  Gopal N Gupta; James Peterson; Kailash N Thakore; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

3.  Active surveillance for small renal masses.

Authors:  Phillip M Pierorazio; Elias S Hyams; Jeffrey K Mullins; Mohamad E Allaf
Journal:  Rev Urol       Date:  2012

4.  A Randomized Study of Patient Risk Perception for Incidental Renal Findings on Diagnostic Imaging Tests.

Authors:  Stella K Kang; Laura D Scherer; Alec J Megibow; Leslie J Higuita; Nathanael Kim; R Scott Braithwaite; Angela Fagerlin
Journal:  AJR Am J Roentgenol       Date:  2017-11-15       Impact factor: 3.959

Review 5.  The role of imaging in the active surveillance of small renal masses.

Authors:  P G K Wagstaff; P J Zondervan; J J M C H de la Rosette; M P Laguna
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 6.  Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.

Authors:  Jacqueline M Speed; Quoc-Dien Trinh; Toni K Choueiri; Maxine Sun
Journal:  Curr Urol Rep       Date:  2017-02       Impact factor: 3.092

Review 7.  Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

Authors:  Marc C Smaldone; Alexander Kutikov; Brian L Egleston; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Michael A Jewett; Richard E Greenberg; Robert G Uzzo
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

Review 8.  Is there a role for adjuvant therapy after surgery in "high risk for recurrence" kidney cancer? An update on current concepts.

Authors:  T Sharma; C Tajzler; A Kapoor
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

Review 9.  Volumetric analysis at abdominal CT: oncologic and non-oncologic applications.

Authors:  Virginia B Planz; Meghan G Lubner; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2018-11-30       Impact factor: 3.039

Review 10.  Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review.

Authors:  Tarek H El-Ghazaly; Ross J Mason; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.